Stay updated with breaking news from Analytical Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Testa Analytical has launched a new 21CFR Part 11 compliance software designed for its NanoBrook particle sizing and zeta potential instrumentation. Click to read more...
10x Genomics (NASDAQ:TXG – Get Free Report) and Revvity (NYSE:RVTY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings. Risk & Volatility 10x Genomics has a beta of […]
Revvity (NYSE:RVTY – Get Free Report) had its price target lowered by The Goldman Sachs Group from $120.00 to $105.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective would suggest a potential upside of 27.21% from the […]
Revvity (NYSE:RVTY – Get Free Report) issued an update on its FY23 earnings guidance on Monday morning. The company provided earnings per share guidance of $4.53-4.57 for the period, compared to the consensus earnings per share estimate of $4.78. The company issued revenue guidance of $2.72-2.74 billion, compared to the consensus revenue estimate of $2.83 […]
Revvity, Inc. (NYSE:RVTY – Get Free Report) has received a consensus rating of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among […]